AstraZeneca Opposes MDL In Nexium Bone Density Suits
AstraZeneca LP on Thursday asked the U.S. Judicial Panel on Multidistrict Litigation not to consolidate nearly 40 individual cases and putative class actions that allege taking the heartburn drug Nexium causes...To view the full article, register now.
Already a subscriber? Click here to view full article